Forum Private Client Group’s JPMorgan Core Plus Bond ETF JCPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6M Buy
714,849
+36,335
+5% +$1.7M 9.99% 2
2026
Q1
$32M Buy
678,514
+37,117
+6% +$1.76M 10.65% 2
2025
Q4
$30.4M Buy
641,397
+31,287
+5% +$1.49M 10.35% 2
2025
Q3
$29M Buy
610,110
+14,452
+2% +$680K 10.34% 2
2025
Q2
$28M Buy
595,658
+28,302
+5% +$1.31M 10.8% 1
2025
Q1
$26.7M Buy
567,356
+28,182
+5% +$1.31M 11.58% 1
2024
Q4
$24.8M Buy
539,174
+36,363
+7% +$1.7M 11.06% 1
2024
Q3
$24.3M Buy
502,811
+36,309
+8% +$1.72M 10.77% 1
2024
Q2
$21.6M Buy
466,502
+50,174
+12% +$2.31M 10.27% 1
2024
Q1
$19.4M Buy
416,328
+66,866
+19% +$3.11M 9.39% 2
2023
Q4
$16.5M Buy
+349,462
New +$15.8M 8.59% 2
2023
Q3
Sell
-213,230
Closed -$9.93M 42
2023
Q2
$9.93M Buy
213,230
+116,066
+119% +$5.46M 5.69% 4
2023
Q1
$4.6M Buy
+97,164
New +$4.56M 2.91% 12

Other funds holding JCPB

Forum Private Client Group's JCPB Position: Q2 2026 in Review

Forum Private Client Group increased its JPMorgan Core Plus Bond ETF (JCPB) stake by 5.4% in Q2 2026, buying an estimated $1.7M and bringing the position to 714,849 shares worth $33.6M. The position accounts for 9.99% of the portfolio, ranked #2.

Forum Private Client Group first reported a position in JCPB in Q1 2023 and has held it in 13 quarters since. 504 funds tracked by Wall St. Rank hold JCPB as of Q2 2026.

  • Forum Private Client Group held 714,849 shares of JPMorgan Core Plus Bond ETF worth $33.6M as of Q2 2026.
  • Forum Private Client Group bought 36,335 JPMorgan Core Plus Bond ETF shares in Q2 2026, an estimated $1.7M.
  • JPMorgan Core Plus Bond ETF made up 9.99% of Forum Private Client Group's portfolio in Q2 2026, its #2 holding.
  • Forum Private Client Group first reported a position in JPMorgan Core Plus Bond ETF in Q1 2023 and has held it in 13 quarters since.
  • 504 funds tracked by Wall St. Rank held JPMorgan Core Plus Bond ETF as of Q2 2026.

Based on Forum Private Client Group's 13F filing for Q2 2026, filed 12 Aug 2026.